Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
07/2008
07/10/2008CA2674239A1 Methods and vectors for generating asialylated immunoglobulins
07/10/2008CA2673229A1 Methods for the synthesis of cyclic peptides
07/09/2008EP1942113A1 Neuronal differentiation inhibitor peptide and use thereof
07/09/2008EP1940864A2 Method for generating anti-variable region monoclonal antibodies
07/09/2008EP1388010B1 Arrays comprising biological membrane microspots
07/09/2008CN101218247A Protein purification using HCIC and ion exchange chromatography
07/09/2008CN101215736A Glycosyl modified acrylonitrile group nano fibre and its preparing method and application
07/09/2008CN101215330A Method for preparing 1-aminohydantoin artificial antigen
07/09/2008CN101215324A Exenatide short peptide simulation peptide and application thereof in preparing medicament for curing diabetes
07/09/2008CN101215322A Artificial antigen and antibody of furazolidone metabolite 3-amino-2-oxazolidone and preparation method thereof
07/09/2008CN101215321A Method for extracting II type epiphyte hydrophobic protein by ultrafiltration method
07/09/2008CN101215320A Method for modifying protein separation action by using ultrasonic enhancement charged ultra-filtration
07/09/2008CN101215319A Technique for extracting fructus trichosanthis seed crude protein
07/09/2008CN101215318A Ultrasonic wave extraction method for lotus seed protein
07/09/2008CN101215317A Method for preparing syngnathus acus linnaeus antineoplastic activity protein
07/09/2008CN101215316A Microwave extraction method for lotus seed protein
07/09/2008CN101215315A Method for extracting sea cucumber collagen and collagen
07/09/2008CN101215314A Process for preparing II type soft bone collagen
07/09/2008CN101214259A Pilose antler basic fibroblast growth factor (DEER FGF) extraction and preparation thereof
07/09/2008CN100400664C Preparation method of fusion protein of tumour blood-targeted peptide and human interferon alpha-2b
07/08/2008US7396925 Volatilizable solid phase supports for compound synthesis
07/08/2008US7396916 Antibody to a polypeptide overexpressed in tumors
07/08/2008US7396908 OAF065alpha and OAF065beta polypeptides
07/08/2008US7396907 Antibodies that bind PRO6182 polypeptides
07/08/2008US7396906 Pro4399 Polypeptides
07/08/2008US7396691 Method for the detection of fluoride or hydrogen fluoride and detection kit
07/08/2008US7396670 Polypeptide of given sequence; reduced formation of acrylamide by treating raw material with enzyme; immersing vegetables into mixture
07/08/2008US7396668 Nicotianamine synthase and gene encoding the same
07/08/2008US7396666 Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid
07/08/2008US7396656 Using transglutaminase to form polymers from fusion peptides; enhances antigenicity; use in vaccines
07/08/2008CA2250712C Chimeric isoprenoid synthases and uses thereof
07/08/2008CA2218884C Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof
07/08/2008CA2218111C Igf-i purification process
07/08/2008CA2150262C Multivalent and multispecific binding proteins, their manufacture and use
07/03/2008WO2008079571A1 Device and method for precipitation of peptides
07/03/2008WO2008079324A1 Immunological modulation of insulin-like growth factor 1 for cancer prevention/treatment and prolonging longevity
07/03/2008WO2008079280A1 Purification of proteins
07/03/2008WO2008077621A1 Method for forming disulfide bridges
07/03/2008WO2008052501B1 Method of obtaining plant protein fractions with a medium molecular weight, plant protein fraction, and its use
07/03/2008US20080161544 Chromatographic separation of therapeutic polypeptides
07/03/2008US20080161538 Pan-antiviral peptides
07/03/2008US20080161537 Selective radiolabeling of biomolecules
07/03/2008US20080160595 Enzymatic polypeptide for use as diagnostic tool in screening parasiticides
07/03/2008US20080160501 Plasma protein-binding ligands
07/03/2008US20080160018 Using mik- beta 1 monoclonal antibody as therapeutic tool in treatment and prevention of graft vs. host, autoimmune and diabetic disorders
07/02/2008EP1939212A1 Organic compounds
07/02/2008EP1939211A1 Polypeptide linked with an organic group
07/02/2008EP1938834A1 Treatment of type 1 diabetes before and after expression of predisposition markers
07/02/2008EP1937708A1 Asymmetric synthesis of peptides
07/02/2008EP1558354A4 Using amines or amino acids as mobile phase modifiers in chromatography
07/02/2008EP1385950B1 Computer-directed assembly of a polynucleotide encoding a target polypeptide
07/02/2008EP1171468B1 Method for the Stabilization of Chimeric Immunoglobulins or Immunoglobulin Fragments, and Stabilized Anti-EGP-2-scFv Fragment
07/02/2008CN101210243A Amino acid sequence and polynucleotide sequence for chicken intestinal canal beta alexin and extraction method thereof
07/02/2008CN101210239A Double-functional molecule for dissolving thrombus and inhibiting blood platelet aggregate and use thereof
07/02/2008CN101210043A Rice bran immune peptide and preparing method thereof
07/02/2008CN101210042A Vessel for culturing protein crystal
07/02/2008CN100398646C Method for preparing new type affiliation carrier
07/02/2008CN100398559C Anti-HBeAg monoclonal antibody and its cell strain, prepn. method and use thereof
07/02/2008CN100398554C Linker compound, ligand, and producing method thereof
07/02/2008CN100398551C Novel isoforms of vascular endothelial cell growth inhibitor
07/01/2008US7393972 Process for preparing amino acid esters and their acid addition salts
07/01/2008US7393942 Nucleic acids encoding mutant forms of Fas ligand
07/01/2008US7393936 Method for the recombinant production and purification of protein kinases
07/01/2008US7393931 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
07/01/2008US7393929 Inhibitors of cellulolytic, xylanolytic and β-glucanolytic enzymes
07/01/2008US7393920 Deprotecting amino acid linked to solid phase resin by admixing with solution in transparent vessel while irradiating with microwaves, coupling/activating/hybridizing amino acids, then cleaving
07/01/2008US7393917 PRO1482 polypeptides
07/01/2008US7393824 Methods of peptide preparation
07/01/2008US7393673 Mixture containing glucanase for use in degradation of plant biomass and pollution control
07/01/2008US7393670 Tyrosyl-tRNA synthetase variants
07/01/2008US7393662 Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
06/2008
06/26/2008WO2008076560A2 Human monoclonal antibodies to btla and methods of use
06/26/2008WO2008074724A1 Organic compounds
06/26/2008WO2008074128A1 Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
06/26/2008WO2008074083A1 Extracting and purifying lipoxygenase
06/26/2008WO2008048124A3 Ssl7 mutants and uses therefor
06/26/2008WO2008048121A3 Macrocyclic cysteine protease inhibitors and compositions thereof
06/26/2008WO2008001109A3 Method of covalently linking a carbohydrate or polyalkylene oxide to a peptide, precursors for use in the method and resultant products
06/26/2008WO2006127514A3 Compositions and methods for treating hiv infection with cupredoxin and cytochrome c
06/26/2008US20080153740 Methods for increasing protein polyethylene glycol (PEG) conjugation
06/26/2008US20080152703 Epitopes formed by non-covalent association of conjugates
06/26/2008US20080152666 Apoptosis-inducing polypeptides
06/26/2008US20080152588 Metal Chelators and Methods of Their Use
06/26/2008CA2673421A1 Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
06/25/2008EP1935901A1 Analysis and separation of platelet-derived growth factor proteins
06/25/2008EP1934606A2 Optimized trpm8 nucleic acid sequences and their use in cell based assays and test kits to identify trpm8 modulators
06/25/2008EP1934242A1 Protein floculation using salts
06/25/2008EP1756128A4 Phosphonium salts derivatives and their use as solubility controlling auxiliaries
06/25/2008EP1546672A4 Microfluidic chip for biomolecule crystallization
06/25/2008EP0859625B1 Composition and methods for enhancing immune responses mediated by antigen-presenting cells
06/25/2008CN101208427A Methods and compositions for amino acid production
06/25/2008CN101208357A Affinity ligands
06/25/2008CN101208353A Isoforms of brain natriuretic peptide
06/25/2008CN101205250A Method for preparing high-purity apolipoprotein A-I
06/25/2008CN101204405A Extractive of locust tree microellobosporia, preparation method and uses thereof
06/24/2008US7390887 Antibodies against PRO4330
06/24/2008US7390886 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
06/24/2008US7390883 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by skeletal cells/adipocytes; for stimulating the release of proteoglycans from cartilage
06/24/2008US7390882 Compositions and methods for the diagnosis and treatment of tumor
06/24/2008US7390881 first component is the modified antigenic ectodomain of measles virus hemagglutinin protein, second component fused to first component that binds a surface protein of human immunodeficiency virus; for treating HIV infection and other therapeutic targets against which it is difficult to develop vaccines